Thailand announces plans for human trials after developing its second COVID-19 vaccine | News from

By February 23, 2021No Comments

The vaccine which was developed by Chulalongkorn University showed promising results in prior trials with mice and monkeys. The University’s Centre of Excellence in Vaccine Research and Development is utilizing new mRNA technology and its clinical testing on transgenic mice showed that the vaccine was able to prevent clinical symptoms and viremia after two shots.
News from

Leave a Reply